ISO Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (20 Mar 2023 @ 16:00):

Stats
Today's Volume	111 017
Average Volume	47 290.00
Market Cap	30.28M
EPS	$-0.840 ( 2023-03-02 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.299
ATR14	$0.110 (14.44%)

Insider Trading

Date	Person	Action	Amount	type
2023-03-21	Khakhar Rajesh T.	Sell	14 583	Common Stock
2023-03-21	Khakhar Rajesh T.	Sell	40 000	Stock Option
2023-03-21	Khakhar Rajesh T.	Sell	31 600	Stock Option
2023-03-21	Myers Jason W.	Sell	40 000	Stock Option
2023-03-21	Myers Jason W.	Sell	89 047	Stock Option

INSIDER POWER
-79.84
Last 98 transactions
Buy: 16 662 811 \| Sell: 5 848 053

Volume Correlation

Long: 0.05 (neutral)

Short: -0.43 (neutral)

Signal:(35.141) Neutral

IsoPlexis Corporation Correlation

10 Most Positive Correlations
RMRM	0.938
SVAC	0.918
TLGT	0.888
PAIC	0.876
MTSL	0.876
FEYE	0.847
DVAX	0.844
GAINL	0.844
GOODM	0.826
ALLO	0.826

10 Most Negative Correlations
LWAC	-0.939
AMRB	-0.915
NETE	-0.896
SRAC	-0.889
MMAC	-0.871
RAVN	-0.85
LEXX	-0.832
LONE	-0.83
LMRKN	-0.827
LCA	-0.815

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

IsoPlexis Corporation Correlation - Currency/Commodity

-0.62
( weak negative )

-0.63
( weak negative )

0.00
( neutral )

0.25
( neutral )

-0.67
( moderate negative )

0.36
( neutral )

IsoPlexis Corporation Financials

Annual	2022
Revenue:	$16.76M
Gross Profit:	$-925 000 (-5.52 %)
EPS:	$-2.94

Q4	2022
Revenue:	$3.36M
Gross Profit:	$-7.81M (-232.49 %)
EPS:	$-0.880

Q3	2022
Revenue:	$4.48M
Gross Profit:	$2.26M (50.33 %)
EPS:	$-0.510

Q2	2022
Revenue:	$4.01M
Gross Profit:	$2.08M (51.84 %)
EPS:	$-0.690

Financial Reports:

No articles found.

IsoPlexis Corporation

IsoPlexis Corporation, a life sciences company, provides solutions for the development of curative medicines and personalized therapeutics in the United States, Canada, the United Kingdom, Belgium, France, the Czech Republic, Spain, Germany, Sweden, Italy, Israel, Switzerland, China and Taiwan, Singapore, Japan, Australia, and Korea. The company offers single cell proteomics platform, including instruments, chip consumables, and software that provides an end-to-end solution to view of protein function at an individual cellular level. It provides IsoLight and IsoSpark instruments; IsoCode chips that offer multiplexed chip solutions for single cell functional proteomics; CodePlex chips that provide multiplexed solutions for ultra-low volume bulk samples; and IsoSpeak software that offers dimensional data and automates analysis with an intuitive push button user interface to deliver same day single cell and bulk proteome visualizations, as well as research support and services, and post-warranty services. The company was incorporated in 2013 and is based in Branford, Connecticut.